Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Maven Clinic vs Next Vial

Maven Clinic
Graded #383

Lower grade

vs+1.2999999999999972
Next Vial
Graded #345

Higher grade

The verdict

Next Vial takes it — 59.3/100 to 58/100, but only just.

Next Vial grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Fully online GLP-1 telehealth marketplace connecting patients with licensed providers for compounded semaglutide and tirzepatide injections, including microdose options. Maven Clinic is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMaven Clinic +5
45
40
Dose & formulationMaven Clinic +1
53
52
Clinical oversightNext Vial +5
77
82
Labs & monitoringMaven Clinic +1
53
52
FulfillmentNext Vial +16
70
86
Contract termsEven
55
55
Maven Clinic · left barNext Vial · right bar

The numbers

MetricMaven ClinicNext Vial
WeighScore58/10059.3/100
GradeCC
Scorecard rank#383#345
SemaglutideNot disclosed$250/mo (compounded)
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published49 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Maven Clinic

Graded #383 · C

Strengths

  • Dedicated GLP-1 Care program with brand-name (FDA-approved) GLP-1 prescriptions
  • On-demand visits with metabolic and hormone-health specialists, plus nutrition and strength support
  • Integrated with broader women's, hormone, and family health care
  • LegitScript-verified; trusted by 2,300+ employers
  • Available as both an employer health benefit and a consumer self-pay option

Where it loses points

  • Pricing is not published on the public site
  • Primarily distributed through employers and health plans — direct access can depend on your plan
  • US state availability for GLP-1 is not specified publicly
  • Brand-name only — no lower-cost compounded option
Next Vial

Graded #345 · C

Strengths

  • LegitScript verified with named pharmacy partner (Manifest Pharmacy, Greer, SC)
  • No membership fees — one all-in price covering consultation, medication, and shipping
  • Compounded semaglutide, tirzepatide, and microdose options available
  • Free rushed shipping; serves 49 states nationwide
  • Board-certified physician oversight with ongoing provider support

Where it loses points

  • Tirzepatide pricing not listed publicly (starting price covers GLP-1 generally)
  • Compounded medications are not FDA-approved
  • Labs and nutritional coaching not disclosed
  • Microdose pricing not published on product page
  • Alaska not listed among served states

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard